A new antibody drug to help fight COVID-19 infection in immune-compromised people may be available by the end of the year. AstraZeneca said Thursday that its treatment, called AZD3152, appears to work in all variants to date, potentially providing necessary armor for immunocompromised people whose vaccinations have not given themContinue Reading